CX Institutional’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.63M | Buy |
97,525
+15,411
| +19% | +$1.24M | 0.22% | 114 |
|
|
2026
Q1 | $7.12M | Buy |
82,114
+2,326
| +3% | +$223K | 0.22% | 110 |
|
|
2025
Q4 | $7.66M | Buy |
79,788
+8,960
| +13% | +$870K | 0.23% | 116 |
|
|
2025
Q3 | $6.75M | Buy |
70,828
+2,161
| +3% | +$199K | 0.2% | 115 |
|
|
2025
Q2 | $5.99M | Buy |
68,667
+60,965
| +792% | +$5.17M | 0.21% | 121 |
|
|
2025
Q1 | $692K | Buy |
7,702
+568
| +8% | +$50.8K | 0.03% | 321 |
|
|
2024
Q4 | $570K | Sell |
7,134
-156
| -2% | -$13.5K | 0.02% | 327 |
|
|
2024
Q3 | $656K | Buy |
7,290
+608
| +9% | +$51.1K | 0.03% | 339 |
|
|
2024
Q2 | $526K | Sell |
6,682
-4
| -0.1% | -$328 | 0.02% | 366 |
|
|
2024
Q1 | $583K | Buy |
6,686
+208
| +3% | +$17.8K | 0.03% | 349 |
|
|
2023
Q4 | $534K | Sell |
6,478
-3,152
| -33% | -$240K | 0.03% | 321 |
|
|
2023
Q3 | $755K | Sell |
9,630
-38
| -0.4% | -$3.18K | 0.04% | 283 |
|
|
2023
Q2 | $852K | Buy |
9,668
+2,702
| +39% | +$233K | 0.04% | 295 |
|
|
2023
Q1 | $557K | Buy |
6,966
+312
| +5% | +$25.4K | 0.03% | 340 |
|
|
2022
Q4 | $517K | Buy |
+6,654
| New | +$539K | 0.03% | 364 |
|
|
2022
Q3 | – | Sell |
-3,454
| Closed | -$310K | – | 869 |
|
|
2022
Q2 | $310K | Buy |
3,454
+332
| +11% | +$33.6K | 0.02% | 381 |
|
|
2022
Q1 | $346K | Buy |
+3,122
| New | +$330K | 0.03% | 297 |
|
|
2021
Q4 | – | Sell |
-2,521
| Closed | -$316K | – | 692 |
|
|
2021
Q3 | $316K | Buy |
2,521
+93
| +4% | +$12K | 0.03% | 310 |
|
|
2021
Q2 | $301K | Buy |
2,428
+324
| +15% | +$40.7K | 0.02% | 297 |
|
|
2021
Q1 | $249K | Buy |
2,104
+351
| +20% | +$41.1K | 0.02% | 284 |
|
|
2020
Q4 | $205K | Buy |
1,753
+394
| +29% | +$43.4K | 0.02% | 290 |
|
|
2020
Q3 | $141K | Sell |
1,359
-17,437
| -93% | -$1.75M | 0.02% | 283 |
|
|
2020
Q2 | $1.72M | Buy |
18,796
+3,026
| +19% | +$290K | 0.23% | 123 |
|
|
2020
Q1 | $1.42M | Buy |
15,770
+15,299
| +3,248% | +$1.63M | 0.23% | 102 |
|
|
2019
Q4 | $53K | Sell |
471
-183
| -28% | -$20.1K | 0.01% | 278 |
|
|
2019
Q3 | $71K | Sell |
654
-1,570
| -71% | -$164K | 0.01% | 274 |
|
|
2019
Q2 | $217K | Buy |
2,224
+1,426
| +179% | +$130K | 0.03% | 215 |
|
|
2019
Q1 | $73K | Buy |
798
+589
| +282% | +$52.7K | 0.01% | 300 |
|
|
2018
Q4 | $19K | Buy |
209
+59
| +39% | +$5.51K | ﹤0.01% | 320 |
|
|
2018
Q3 | $15K | Hold |
150
| – | – | 0.01% | 237 |
|
|
2018
Q2 | $13K | Buy |
+150
| New | +$12.5K | ﹤0.01% | 219 |
|
Other funds holding MDT
CX Institutional's MDT Position: Q2 2026 in Review
CX Institutional increased its Medtronic (MDT) stake by 19% in Q2 2026, buying an estimated $1.24M and bringing the position to 97,525 shares worth $7.63M. The position accounts for 0.22% of the portfolio, ranked #114.
CX Institutional first reported a position in MDT in Q2 2018 and has held it in 31 quarters since. The position peaked at $7.66M in Q4 2025. 2,131 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- CX Institutional held 97,525 shares of Medtronic worth $7.63M as of Q2 2026.
- CX Institutional bought 15,411 Medtronic shares in Q2 2026, an estimated $1.24M.
- Medtronic made up 0.22% of CX Institutional's portfolio in Q2 2026, its #114 holding.
- CX Institutional first reported a position in Medtronic in Q2 2018 and has held it in 31 quarters since.
- CX Institutional's Medtronic position peaked at $7.66M in Q4 2025.
- 2,131 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.